Kivelä et al (2014) find that a VEGF-B transgenic rat strain (expressing the 167 and 186 isoform) presented physiologic cardiac hypertrophy, without developing the cardiomyopathy reported in VEGF-B167 mice (Karpanen et al, 2008). Here, VEGFB is linked to cardiomyopathy.